Slide 1: BioLargo Q2 2024 Earnings Webcast and Conference Call
iS BioLargo We Make Life Better Q2 2024 Earnings Webcast and Conference Call August 14, 2024 Stock Symbol: BLGO
Slide 2: Safe Harbor Statement
Safe Harbor Statement
Slide 3: Who we are
Who we are > Innovators, > Passionate about > Driven by a mission scientists, engineers, sustainability and to make life better and entrepreneurs human health
Slide 4: What we do
What we do > Best-in-class > Engineering-forward > Focus on problems solutions for technologies without good cleantech problems solutions
Slide 5: Operating Segments
Operating Segments Commercializing our Technologies The BioLargo Innovation Engine 11 BioLargo Biobergo | |G Siv84) @ENERSY We Make Life Better Gp Biokargo — evrcaws = BioLargo (5 Biokargo — ko G8elego 5
Slide 6: Quarterly Revenue and SG&A: Key highlights from Q2 2024
QUARTERLY REVENUE AND SG&A Key highlights from|Q2 2024: eheverve HeSG8A Record Revenue: ‘ + $5.0 million for the quarter + 247% increase compared to Q2 last year, and 5% increase quarter over s quarter Net Loss: ¥ + $780,000 for the quarter, including $663,000 in non-cash equity compensation expense
Slide 7: 2024 Revenue Run Rate
$ MILLIONS 2024 REVENUE RUN RATE Current revenue run rate + YTD revenues were $9.773 million * Our current annual reve run rate is $19.5 milli ue Trends are not necessarily indicative of future performance, and future revenues are highly dependent on ‘our partners’ performance. 2018 2019 2020 «2021
Slide 8: Net Stockholder's Equity
MILLIONS $8) NET STOCKHOLDER'S EQUITY 2018 2019 020 Trends are not necessarily indicative of future performance 2021 2022 2023 Q2 OF 2024
Slide 9: a < S po S
a < 5 S po S 5
Slide 10: Major Retail Outlets
Major Retail Outlets }amazon..| Walmart >\< [alave ACE VES D>
Slide 11: POOPH - Consumer pet odor product
POOPH - Consumer pet odor product Product marketed and sold by our partners, award-winning consumer product experts (Pooph, Inc.) ONM receives manufacturer's margin and a royalty on sales Business strategy: ramp up sales and sell to a major consumer products company + ONM would receive 20% of exit (
Slide 12: Pooph - Looking Forward
Pooph - Looking Forward Fantastic historic performance Pooph's Inc.'s goals for their brand: * Continued 20% QoQ growth (~100% YoY) + 80,000 stores Wipes and Litterizer both launched Pooph Potty Pads coming soon to a retailer near you Ongoing discussions about expanding product category
Slide 13: Clyra Medical Technologies
Ocves Clyra Medical Technologies: THE CLYRADVANTAGE Clyra™ Antimicrobial Platform {Infection Prevention & Control Supporting 3"-party FDA-compliant manufacturing with >$1.3 million of specialized equipment to support upcoming distribution
Slide 14: Progress Made, Capital Invested
Progress Made, 7 Ne Capital Invested keystae Ne tndustrie Preparing for scaled manufacturing Keystone Industries Two new surgical products Special equipment Custom molds
Slide 15: PFAS: the Forever Chemicals Plaguing Water Supplies
PFAS: the “Forever Chemicals” Plaguing Water Supplies Around — the World of sites — including public s, and industrial plants — dentified
Slide 16: PFAS By the Numbers
PFAS By the Numbers «Industry's cost to purchase PFAS: $50-1,000 per Ib *PFAS removal cost from wastewater: $2.7M-18M per Ib * Yearly cost of PFAS remediation to society: $17.5T Top 12 companies responsible for PFAS production AGC, Arkema, Chemours, Daikin, 3M, Solvay, Dongyue, Archroma, Merck, Baye
Slide 17: The PFAS treatment waste conundrum
The PFAS treatment waste conundrum | what they don’t tell you about other PFA capture technologies AEC produces less waste Disposal of PFAS-laden waste is expensive, difficult, and has regulatory implications
Slide 18: Lake Stockholm System Project Update
Lake Stockholm System Project Update + November ~ first install of an AEC + "Reference customer” — crucial to enabling further adoption GBiotergo 18
Slide 19: PFAS - More than just water treatment
PFAS — More than just water treatment New markets coming online in anticipation of new regulations Leachate treatment AFFF treatment Hundreds of highly contaminated military sites and airports around the country Wastewater and ‘Why?: ales Industrial Other PFAS concentration techs can't handle the co
Slide 20: GAC-based filtration
GAC-based filtration The PFAS treatment waste conundrum don't tell you about What the other PAS capture technologies 10 Year if Cycle Costs a8 Function of Waste Disposal Costs
Slide 21: Cellinity by BioLargo Energy Technologies
\OO} C=LLINITY BY BIOLARGO ENERGY TECHNOLOGIES Better, safer, more affordable, longer lasting option for long duration energy storage
Slide 22: Cellinity Video
Cellinity Video
Slide 23: Why choose Cellinity instead of lithium ion?
Why choose Cellinity instead of lithium ion? Safety factors Ecological factors Climate sensitivity ‘Supply chain factors Self discharge Useful life ‘Accessible energy (min/max state of charge) ‘Average price of battery ystems (S/ewh,utility-seale systems, 2022 dollars) Price comparison to Tesla ‘/ke
Slide 24: Initially targeting two BESS module sizes
Initially targeting two BESS module sizes: 2 MW ~25 KWh Demand is unprecedented — EOS Energy reports a commercial pipeline of $13.3 billion, and an order backlog of $600 million. Government incentives drive adoption: DOE clean energy finance program, inflation reduction act tax credits (30%), “Made
Slide 25: BioLargo battery manufacturing facility, Oak Ridge, Tennessee
BioLargo battery manufacturing facility, Oak Ridge, Tennessee
Slide 26: First Battery Cells Now Manufactured
First Battery Cells Now Manufactured BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion WESTMINSTER, CA /ACCESSWIRE /June 11,2024 / TOQX:BLGO), Liquid So
Slide 27: Business model: Sell factories, not batteries
Business model: Sell factories, not batteries Develop region-specific factories that are owned and operated locally, with BioLargo holding a minority position Focus on. + Adapt capacity to meet demand scale: giga- vs micro-factory + Workforce development + Region-specific needs + Microgrid deploymen
Slide 28: Proposed Factory Business Model
Proposed Factory Business Model REPRESENTATIVE BATTERY FACTORY PARTNERSHIP PROJECT Development Operational T $60 milion revenue 25 years BET receives 10 BETI on average project + 6% Royalty (engineering, equipment, + % of profits based on ownership training etc) ‘+ Revenues from component supply * 1
Slide 29: The BioLargo Family of Companies
The BioLargo (b BioLargo Family of Companies ————— BioLargo In. sa sustainable science, technology & fll-serv hat makeslifebetter by deliv 05 broad range of industries, with a drive to deliver 1d advanced antimicrobials for healthcare. sep. eed OTCQB: | OyBioL.arge BLGO CLYRA ° (Bicteroo Dennis Calv